Association of prior radiation dose to the cardiopulmonary system with COVID-19 outcomes in patients with cancer
Radiother Oncol
.
2021 Aug:161:115-117.
doi: 10.1016/j.radonc.2021.06.002.
Epub 2021 Jun 6.
Authors
Quincey LaPlant
1
,
Maria Thor
2
,
Narek Shaverdian
3
,
Jacob Y Shin
3
,
Philip Gilbo
3
,
Jia Luo
4
,
Daniel R Gomez
3
,
Daphna Y Gelblum
3
Affiliations
1
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address:
[email protected]
.
2
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA.
3
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, USA.
4
Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
PMID:
34107295
PMCID:
PMC8180359
DOI:
10.1016/j.radonc.2021.06.002
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19*
Heart / radiation effects
Humans
Lung / radiation effects
Neoplasms* / radiotherapy
Radiation Dosage
Grants and funding
P30 CA008748/CA/NCI NIH HHS/United States
T32 CA009207/CA/NCI NIH HHS/United States
5 P30 CA008748-54/NH/NIH HHS/United States
K30 UL1TR00457/NH/NIH HHS/United States